Ascendis Pharma A/SASNDNASDAQ
Loading
Research and development spending
3Y CAGR
-9.3%/yr
vs +28.3%/yr prior
5Y CAGR
+1.7%/yr
Recent deceleration
Acceleration
-37.5pp
Decelerating
Percentile
P69
Within normal range
vs 5Y Ago
1.1x
Modest growth
Streak
2 yr
Consecutive declineStable
| Period | Value | YoY Change |
|---|---|---|
| 2025 | $283.50M | -7.7% |
| 2024 | $307.00M | -25.7% |
| 2023 | $413.45M | +8.9% |
| 2022 | $379.62M | +28.3% |
| 2021 | $295.87M | +13.4% |
| 2020 | $260.90M | +36.2% |
| 2019 | $191.62M | +36.6% |
| 2018 | $140.28M | +40.9% |
| 2017 | $99.59M | +50.8% |
| 2016 | $66.02M | - |